{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:09:26Z","timestamp":1790111366645,"version":"4.0.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020756","name":"Shanghai Professional Technology Service Platform on Cold Chain Equipment Performance and Energy Saving Testing Evaluation","doi-asserted-by":"publisher","award":["CYQN2021062"],"award-info":[{"award-number":["CYQN2021062"]}],"id":[{"id":"10.13039\/501100020756","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejpb.2026.115144","type":"journal-article","created":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T15:47:19Z","timestamp":1781020039000},"page":"115144","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Study on the improvement of bioavailability and hepatoprotective effect of silybin-7-eicosanedioate long-acting injection based on prodrug technology"],"prefix":"10.1016","volume":"226","author":[{"given":"Junyi","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baojuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanting","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youfa","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2875-355X","authenticated-orcid":false,"given":"Xin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115144_b0005","doi-asserted-by":"crossref","first-page":"66","DOI":"10.21037\/hbsn-2024-754","article-title":"2024 latest report on hepatitis B virus epidemiology in China: current status, changing trajectory, and challenges","volume":"14","author":"Yan","year":"2025","journal-title":"Hepatobiliary Surg. Nutr."},{"key":"10.1016\/j.ejpb.2026.115144_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.987324","article-title":"Advances in multi-omics research on viral hepatitis","volume":"13","author":"Xiang","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ejpb.2026.115144_b0015","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1002\/hep.29228","article-title":"Autoimmune-like chronic hepatitis induced by olmesartan","volume":"66","author":"Barge","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ejpb.2026.115144_b0020","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41395-018-0154-0","article-title":"Severe alcoholic hepatitis in a teetotaler","volume":"113","author":"Philips","year":"2018","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2026.115144_b0025","doi-asserted-by":"crossref","first-page":"10052","DOI":"10.12998\/wjcc.v9.i33.10052","article-title":"Effects of alcohol consumption on viral hepatitis B and C","volume":"9","author":"Xu","year":"2021","journal-title":"World J. Clin. Cases"},{"key":"10.1016\/j.ejpb.2026.115144_b0030","first-page":"205","article-title":"Retrospective analysis of 83 cases of drug-induced liver injury and application of hepatoprotective drugs","volume":"25","author":"Nani","year":"2023","journal-title":"Chin. J. Med. Guide"},{"key":"10.1016\/j.ejpb.2026.115144_b0035","unstructured":"Z. Tingting, Z. Yan, Y. Xiaoli, W. Heng. A retrospective study and analysis of drug-induced liver injury at our hospital. The Journal of Medical Theory and Practice 36, 2107\u20132108, 2106 (2023)."},{"key":"10.1016\/j.ejpb.2026.115144_b0040","unstructured":"Y. Lecheng, L. Hongling, Z. Xinyan, M. Shiwu, C. Chengwei. Essential introduction and related reflections on the 2021 edition of the ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury. Liver 26, 465\u2013476 (2021)."},{"key":"10.1016\/j.ejpb.2026.115144_b0045","first-page":"128","article-title":"Application effect of liver disease treatment device combined with behavioral habit reversal therapy in the care of patients with chronic hepatitis","volume":"36","author":"Bei","year":"2023","journal-title":"Chin. J. Med. Device"},{"key":"10.1016\/j.ejpb.2026.115144_b0050","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.3390\/molecules22111942","article-title":"A major bioactive component of milk thistle (Silybum marianum L. Gaernt.)-chemistry, bioavailability, and metabolism","volume":"22","author":"Bijak","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115144_b0055","first-page":"569","article-title":"Silybin-phosphatidylcholine complex protects human gastric and liver cells from oxidative stress","volume":"29","author":"Federico","year":"2015","journal-title":"In Vivo"},{"key":"10.1016\/j.ejpb.2026.115144_b0060","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1039\/C3NP70122K","article-title":"Chemistry of silybin","volume":"31","author":"Biedermann","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejpb.2026.115144_b0065","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.jpba.2007.06.026","article-title":"Analysis of silibinin in rat plasma and bile for hepatobiliary excretion and oral bioavailability application","volume":"45","author":"Wu","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2026.115144_b0070","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.3748\/wjg.v17.i13.1694","article-title":"Legalon-SIL downregulates HCV core and NS5A in human hepatocytes expressing full-length HCV","volume":"17","author":"Mehrab-Mohseni","year":"2011","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejpb.2026.115144_b0075","first-page":"491","article-title":"Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine","volume":"124","author":"Pradhan","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.ejpb.2026.115144_b0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1124\/dmd.107.017566","article-title":"Pharmacokinetics and metabolic profile of free, conjugated, and total silymarin flavonolignans in human plasma after oral administration of milk thistle extract","volume":"36","author":"Wen","year":"2008","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2026.115144_b0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ejmech.2018.01.036","article-title":"Regioselective synthesis of 7-O-esters of the flavonolignan silibinin and SARs lead to compounds with overadditive neuroprotective effects","volume":"146","author":"Schramm","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejpb.2026.115144_b0090","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.ejmech.2009.11.056","article-title":"Antioxidant and antiviral activities of silybin fatty acid conjugates","volume":"45","author":"Ga\u017e\u00e1k","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejpb.2026.115144_b0095","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/mc.20595","article-title":"Silibinin inhibits human nonsmall cell lung cancer cell growth through cell-cycle arrest by modulating expression and function of key cell-cycle regulators","volume":"49","author":"Mateen","year":"2010","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ejpb.2026.115144_b0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3390\/molecules24010061","article-title":"Dermal delivery of selected Polyphenols from Silybum marianum. Theoretical and experimental study","volume":"24","author":"Kosina","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.ejpb.2026.115144_b0105","unstructured":"Complete isolation and characterization of silybins and isosilybins from milk thistle (Silybum marianum).,Organic & Biomolecular Chemistry - X-MOL. https:\/\/www.x-mol.com\/paper\/3116051."},{"key":"10.1016\/j.ejpb.2026.115144_b0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1124\/dmd.113.054353","article-title":"Identification of carboxylesterase-dependent dabigatran etexilate hydrolysis","volume":"42","author":"Laizure","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejpb.2026.115144_b0115","article-title":"Pig liver esterases hydrolyze endocannabinoids and promote inflammatory response","volume":"12","author":"Zhou","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2026.115144_b0120","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ptr.5768","article-title":"Effects of silymarin on diabetes mellitus complications: a review","volume":"31","author":"Stolf","year":"2017","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejpb.2026.115144_b0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116478","article-title":"Investigation on the solid-phase synthesis of silybin prodrugs and their timed-release","volume":"50","author":"Romanucci","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejpb.2026.115144_b0130","article-title":"Nanoparticulation of prodrug into medicines for cancer therapy","volume":"8","author":"Zhang","year":"2021","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.ejpb.2026.115144_b0135","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2174\/138920112802273353","article-title":"Legalon\u00ae SIL: the antidote of choice in patients with acute hepatotoxicity from amatoxin poisoning","volume":"13","author":"Mengs","year":"2012","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115144_b0140","unstructured":"Z. Xue, et al., 2018. Domestic and international research progress on novel injectable drugs. Progress in Pharmaceutical Sciences 42, (2018)."},{"key":"10.1016\/j.ejpb.2026.115144_b0145","first-page":"2481","article-title":"In vitro characterization and pharmacokinetic study of paliperidone palmitate extended-release injection","volume":"42","author":"Junfeng","year":"2022","journal-title":"Chin. J. Hospital Pharm."},{"key":"10.1016\/j.ejpb.2026.115144_b0150","article-title":"Preparation and evaluation of ZL004 long-acting injectable","author":"Zongwei","year":"2017","journal-title":"(China National Pharmaceutical Industry Research Institute"},{"key":"10.1016\/j.ejpb.2026.115144_b0155","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.nano.2017.07.014","article-title":"In vivo fate of lipid-silybin conjugate nanoparticles: Implications on enhanced oral bioavailability","volume":"13","author":"Ma","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ejpb.2026.115144_b0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1208\/s12249-019-1504-y","article-title":"Liver targeting albumin-coated silybin-phospholipid particles prepared by NabTM technology for improving treatment effect of acute liver damage in intravenous administration","volume":"20","author":"Lu","year":"2019","journal-title":"AAPS PharmSciTech"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001657?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001657?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:39:10Z","timestamp":1790109550000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001657"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":32,"alternative-id":["S0939641126001657"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115144","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Study on the improvement of bioavailability and hepatoprotective effect of silybin-7-eicosanedioate long-acting injection based on prodrug technology","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115144","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115144"}}